TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.

Huy X Ngo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.